GSK-945237 Uses, Dosage, Side Effects and more
GSK-945237 is under investigation in clinical trial NCT01039610 (A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.).
| Trade Name | GSK-945237 |
| Generic | GSK-945237 |
| Type | |
| Formula | C24H26FN5O3 |
| Weight | Average: 451.502 Monoisotopic: 451.20196788 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
